Related Experiment Video

Updated: May 15, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Myocardial protection in pediatric cardiac surgery

Rıza Turkoz1

  • 1Department of Cardiovascular Surgery, Istanbul Teaching and Medical Research Center, Başkent University, Istanbul, Turkey. rturkoz@yahoo.com

Artificial Organs
|January 12, 2013
PubMed

Insights

Hypothermia combined with cardioplegic arrest is standard for myocardial protection in pediatric cardiac surgery. Special considerations are needed for immature hearts, complex cases, and newborns to optimize outcomes.

Area of Science:

  • Pediatric Cardiac Surgery
  • Cardiovascular Surgery
  • Myocardial Protection Strategies

Background:

  • Hypothermia and cardioplegic arrest are the most common methods for myocardial protection.
  • Historically, blood was added to cardioplegia solutions for oxygen and nutrient delivery.
  • Pediatric hearts possess unique immature characteristics distinct from adult hearts, impacting protection strategies.

Purpose of the Study:

  • To review myocardial protection methods specifically in pediatric cardiac surgery.
  • To highlight the challenges and adaptations required for protecting immature pediatric myocardium.
  • To emphasize the need for reassessment of protection strategies when outcomes are suboptimal.

Main Methods:

  • Review of established and evolving myocardial protection techniques in pediatric cardiac surgery.
  • Discussion of the historical integration of blood into cardioplegia solutions.
  • Analysis of specific challenging pediatric cardiac surgery scenarios.

Main Results:

  • Pediatric myocardial protection requires tailored approaches due to immature cardiac physiology.
  • Normothermic perfusion and cardioplegia have been adopted in pediatric cases.
  • Challenges arise in complex, long procedures, neonates, and pre-damaged myocardium.

Conclusions:

  • Myocardial protection in pediatric cardiac surgery is complex and requires careful consideration of patient-specific factors.
  • Suboptimal outcomes in complex pediatric cardiac procedures necessitate re-evaluation of myocardial protection protocols.
  • Continuous adaptation of protection strategies is crucial for improving pediatric cardiac surgery results.

More Related Videos

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...